Endocrine-Related Adverse Conditions in Pediatric Patients Treated with Immune Checkpoint Inhibitors: a Position Statement from the Clinical Practice Committee of the European Society for Pediatric Endocrinology (ESPE).
Scope
As issued by the authors
Current knowledge and gaps on ICI immune-related adverse events on the endocrine system in children and adolescents; most frequent endocrine immune-related adverse events (irAEs): adrenal insufficiency, diabetes, thyroid dysfunction, hypophysitis
Original publication
Endocrine-Related Adverse Conditions in Pediatric Patients Treated with Immune Checkpoint Inhibitors: a Position Statement from the Clinical Practice Committee of the European Society for Pediatric Endocrinology (ESPE). Horm Res Paediatr. Published 29 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →